Literature DB >> 23067245

Influence of the valine zipper region on the structure and aggregation of the basic leucine zipper (bZIP) domain of activating transcription factor 5 (ATF5).

Natalie A Ciaccio1, T Steele Reynolds, C Russell Middaugh, Jennifer S Laurence.   

Abstract

Protein aggregation is a major problem for biopharmaceuticals. While the control of aggregation is critically important for the future of protein pharmaceuticals, mechanisms of aggregate assembly, particularly the role that structure plays, are still poorly understood. Increasing evidence indicates that partially folded intermediates critically influence the aggregation pathway. We have previously reported the use of the basic leucine zipper (bZIP) domain of activating transcription factor 5 (ATF5) as a partially folded model system to investigate protein aggregation. This domain contains three regions with differing structural propensity: a N-terminal polybasic region, a central helical leucine zipper region, and a C-terminal extended valine zipper region. Additionally, a centrally positioned cysteine residue readily forms an intermolecular disulfide bond that reduces aggregation. Computational analysis of ATF5 predicts that the valine zipper region facilitates self-association. Here we test this hypothesis using a truncated mutant lacking the C-terminal valine zipper region. We compare the structure and aggregation of this mutant to the wild-type (WT) form under both reducing and nonreducing conditions. Our data indicate that removal of this region results in a loss of α-helical structure in the leucine zipper and a change in the mechanism of self-association. The mutant form displays increased association at low temperature but improved resistance to thermally induced aggregation.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23067245      PMCID: PMC3535187          DOI: 10.1021/mp300288n

Source DB:  PubMed          Journal:  Mol Pharm        ISSN: 1543-8384            Impact factor:   4.939


  59 in total

Review 1.  The workings of the amyloid diseases.

Authors:  Vittorio Bellotti; Mario Nuvolone; Sofia Giorgetti; Laura Obici; Giovanni Palladini; Paola Russo; Francesca Lavatelli; Vittorio Perfetti; Giampaolo Merlini
Journal:  Ann Med       Date:  2007       Impact factor: 4.709

Review 2.  Molecular mechanisms of polypeptide aggregation in human diseases.

Authors:  Sagar D Khare; Nikolay V Dokholyan
Journal:  Curr Protein Pept Sci       Date:  2007-12       Impact factor: 3.272

Review 3.  Recent structural and computational insights into conformational diseases.

Authors:  Xavier Fernàndez-Busquets; Natalia S de Groot; Daniel Fernandez; Salvador Ventura
Journal:  Curr Med Chem       Date:  2008       Impact factor: 4.530

4.  Structure and dynamics of a partially folded protein are decoupled from its mechanism of aggregation.

Authors:  Giulia Calloni; Christofer Lendel; Silvia Campioni; Silva Giannini; Alessandra Gliozzi; Annalisa Relini; Michele Vendruscolo; Christopher M Dobson; Xavier Salvatella; Fabrizio Chiti
Journal:  J Am Chem Soc       Date:  2008-09-04       Impact factor: 15.419

5.  Thermodynamics of denaturation of hisactophilin, a beta-trefoil protein.

Authors:  C Liu; D Chu; R D Wideman; R S Houliston; H J Wong; E M Meiering
Journal:  Biochemistry       Date:  2001-04-03       Impact factor: 3.162

6.  Structural characterization of the partially folded intermediates of an immunoglobulin light chain leading to amyloid fibrillation and amorphous aggregation.

Authors:  Zhijie Qin; Dongmei Hu; Min Zhu; Anthony L Fink
Journal:  Biochemistry       Date:  2007-02-22       Impact factor: 3.162

Review 7.  Contrasting disease and nondisease protein aggregation by molecular simulation.

Authors:  Nicolas Lux Fawzi; Eng-Hui Yap; Yuka Okabe; Kevin L Kohlstedt; Scott P Brown; Teresa Head-Gordon
Journal:  Acc Chem Res       Date:  2008-07-23       Impact factor: 22.384

8.  Evidence for a repeating cross-beta sheet structure in the adenovirus fibre.

Authors:  N M Green; N G Wrigley; W C Russell; S R Martin; A D McLachlan
Journal:  EMBO J       Date:  1983       Impact factor: 11.598

9.  Bacterial inclusion bodies contain amyloid-like structure.

Authors:  Lei Wang; Samir K Maji; Michael R Sawaya; David Eisenberg; Roland Riek
Journal:  PLoS Biol       Date:  2008-08-05       Impact factor: 8.029

Review 10.  Extrinsic fluorescent dyes as tools for protein characterization.

Authors:  Andrea Hawe; Marc Sutter; Wim Jiskoot
Journal:  Pharm Res       Date:  2008-01-03       Impact factor: 4.200

View more
  2 in total

1.  Regression/eradication of gliomas in mice by a systemically-deliverable ATF5 dominant-negative peptide.

Authors:  Charles C Cates; Angelo D Arias; Lynn S Nakayama Wong; Michael W Lamé; Maxim Sidorov; Geraldine Cayanan; Douglas J Rowland; Jennifer Fung; Georg Karpel-Massler; Markus D Siegelin; Lloyd A Greene; James M Angelastro
Journal:  Oncotarget       Date:  2016-03-15

Review 2.  The transcription factor ATF5: role in cellular differentiation, stress responses, and cancer.

Authors:  Thomas K Sears; James M Angelastro
Journal:  Oncotarget       Date:  2017-09-20
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.